Zoetis said total revenue for the 3 months ended June 30, 2025 increased $99 million, or 4%, compared with the prior year period, and increased $113, or 5%, on an operational basis. The company cited a volume decrease related to the impact of the MFA divestiture of approximately 4%.

1. 01

   Zoetis said total revenue for the 3 months ended June 30, 2025 increased $99 million, or 4%, compared with the prior year period, and increased $113, or 5%, on an operational basis. The company cited a volume decrease related to the impact of the MFA divestiture of approximately 4%.

2. 02

   Zoetis said cost of sales as a percentage of revenue was 26.4% for the 3 months ended, compared with 28.3% in the prior year period, and 27.2% for the 6 months ended, compared with 28.8% in the prior year period. The company cited the favorable impact of the MFA divestiture, favorable foreign exchange and price increases as factors in the decrease, partially offset by unfavorable manufacturing and other costs.

3. 03

   Zoetis said net cash used in investing activities for the 6 months ended June 30, 2025 was $422 million, and net cash used in financing activities was $1,241 million. The company repurchased 4.8 million shares for $781 million during the period and said $4.9 billion remained available under its $6 billion share repurchase authorization as of June 30.

4. 04

   Zoetis said its effective tax rate was 20.4% for the 3 months ended, compared with 20.0% in the prior year period, and 21.2% for the 6 months ended, compared with 19.9% in the prior year period. The company said approximately 41% of revenue for the 6 months ended was denominated in foreign currencies, and year-over-year total revenue growth was unfavorably impacted by approximately 2% from changes in foreign currency values relative to the U.S. dollar.

Key figures

Quarter ended June 30, 2025

Revenue

$2.5B

Net income

$718M

EPS

$1.61

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.